News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Labopharm (DDS.TO) to Appeal FDA's Tramadol Decision



11/25/2007 9:28:05 PM

TORONTO, Nov 21 (Reuters) - Labopharm Inc (DDS.TO: Quote, Profile, Research) said on Wednesday the U.S. Food and Drug Administration responded to its appeal of the approvable letter for its once-daily tramadol, and that the agency will not overturn the letter, which was issued in May.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES